FDA Approves Use of Med for Thyroid Cancer

FDA Approves Use of Med for Thyroid Cancer

For the first time in 40 years, the Food and Drug Administration has approved a new drug to treat advanced thyroid cancer.

For the first time in 40 years, the Food and Drug Administration has approved a new drug to treat advanced thyroid cancer.

Freeman Oncologist Amir Anis explains, "The thyroid is a gland that is located in the neck area.The function of the thyroid in the adult population is primarily to maintain the metabolism. It secretes hormones."

And a recent study estimates more than 60,000 patients will be diagnosed this year... and 2,000 of those will likely not make it. But now there's a new option for treating some of the worst cases. Says Dr. Anis, "At a certain point when the cancer was progressing and not responding to treatment, we were limited. But now we have the new drug called Nexavar which is helpful as an additional tool in addressing those patients whose cancer was resistant and continued to progress in the standard treatment that we had."

It's significant progress since in the past, chemotherapy had had only limited success treating thyroid cancer. "This new drug helps to contain the cancer once they become resistant to radioactive iodine treatment." Nexavar is an oral medication taken twice a day and is available at sites like QuickMeds Pharmacy. "Basically this new medication helps to contain the progression of the cancer."

Page: [[$index + 1]]
comments powered by Disqus